Goldman Sachs added Halma plc (LSE:HLMA) to its European Conviction List with a 5,010p target, implying ~27% upside, as the safety technology group bolsters growth through cash-funded, debt-free acquisitions—Naslund Medical for $45M and itemedical for €23M—adding modest revenues.
Previous Week Recap
- Goldman Sachs Upside Target On Halma: Goldman Sachs added Halma plc (HLMA) to its European Conviction List with a 5,010p price target, implying about 27% upside from the recent close near 3,934p.
- Halma Buys Naslund, itemedical: Halma (HLMA) bought Naslund Medical for $45M and agreed to buy itemedical for €23M, both cash, debt-free, funded from existing facilities; Naslund revenue $9.2M, itemedical €7.8M.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.